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Abstract
Background: New strategies for high-throughput sequencing are constantly appearing, leading to a great increase
in the number of completely sequenced genomes. Unfortunately, computational genome annotation is out of step
with this progress. Thus, the accurate annotation of these genomes has become a bottleneck of knowledge
acquisition.
Results: We exploited a proteogenomic approach to improve conventional genome annotation by integrating
proteomic data with genomic information. Using Shigella flexneri 2a as a model, we identified total 823 proteins,
including 187 hypothetical proteins. Among them, three annotated ORFs were extended upstream through
comprehensive analysis against an in-house N-terminal extension database. Two genes, which could not be
translated to their full length because of stop codon ‘mutations’ induced by genome sequencing errors, were
revised and annotated as fully functional genes. Above all, seven new ORFs were discovered, which were not
predicted in S. flexneri 2a str.301 by any other annotation approaches. The transcripts of four novel ORFs were
confirmed by RT-PCR assay. Additionally, most of these novel ORFs were overlapping genes, some even nested
within the coding region of other known genes.
Conclusions: Our findings demonstrate that current Shigella genome annotation methods are not perfect and
need to be improved. Apart from the validation of predicted genes at the protein level, the additional features of
proteogenomic tools include revision of annotation errors and discovery of novel ORFs. The complementary
dataset could provide more targets for those interested in Shigella to perform functional studies.
Background
New sequencing strategies are constantly under develop-
ment and are currently able to process a large number of
samples with great efficiency in a short period of time.
However, accurate annotation of the resulting sequenced
genomes has become the bottleneck of knowledge acquisi-
tion. Conventionally, most genome sequences are anno-
tated with multiple gene prediction algorithms such as
GLIMMER, CRITICA, and GeneMark, or by manual
assignment based on BLAST search results [1,2]. Gene
density is sufficiently high in prokaryotes, such that coding
sequences (CDSs) frequently overlap. Moreover, exon-
intron structures present in eukaryotic genomes also make
computational annotation difficult. These annotations are
rarely experimentally validated, though in silico annotation
methods could be executed with both high speed and
good coverage [3]. The predicted genes exhibit frequent
errors, particularly in false recognition of alternative start
codons, underestimate of short CDSs, misannotation of
pseudogenes, and confusion over overlapping genes.
Previous studies have demonstrated that error rates in the
definition of translation start sites (TSSs) varied from 10%
to 40% in some bacterial and archaeal genomes, according
to different computational methods used [4,5]. Likewise,
after analysis of overlaps larger than 60 bp among 338 pro-
karyotic genomes, it was found that the annotation of
most previously identified genes was incorrect [6]. In these
cases, computational methods were unable to recognize
mutations induced by sequencing errors, such as frame-
shifts and stop codon mutations. As such, there is a great
need for further experimental validation or complemen-
tary annotation approaches for conventional genome
annotation.
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methods are used to address difficulties in gene annota-
tion. Unambiguous identification of proteins by MS is
more explicit and confident than that from genomic
sequence data alone. The high-throughput nature of shot-
gun proteomics makes this technology cost-effective and
readily reliable to the automated genome annotation pro-
cess [7,8]. Integrating proteomic information into the gen-
ome annotation process, termed proteogenomics [9],
directly maps tandem mass spectrometry (MS/MS) spectra
data against all six possible reading frames from raw geno-
mic DNA sequences, i.e., experimental proteomic data can
be fed back to the genome to aid in the validation of pre-
dicted protein-coding genes, potentially avoiding any
biases in the computer algorithm. Proteogenomics analysis
have already been applied to a number of sequenced pro-
karyotes and eukaryotes such as the Mycoplasma pneumo-
nia [7], Mycobacterium lepra [10], Shewanella oneldensis
[11], Mycoplasma mobile [12], Toxplasma gondii [13],
Arabidopsis thaliana [14], human [15] and so on. As a
complementary annotation approach, proteomic methods
are important for improving the quality of genome anno-
tation, especially for correction of start codon errors by
the analysis of a new framework and sequencing of N-
terminally acetylated peptides [16-18] and discovery of
novel genes missed in the computational genome annota-
tion process [19-23]. Although proteogenomics has made
great progress in recent past years, it still highly depends
on the results of MS identification, which has its inherent
drawbacks, including over representation of highly
expressed proteins/peptides and incomplete sampling.
Moreover, the sensitivity and throughput of mass spectro-
meters are also important factors to maximize the benefits
of proteogenomic approaches.
Shigella flexneri is the primary causative agent of ende-
mic shigellosis in developing countries [24]. Its genome
shares a large proportion of chromosomal genes with the
model organism E. coli.S i n c e2 0 0 2 ,t h eg e n o m e so ff o u r
representative strains of species in the family Shigella
spp. have been sequenced [25,26]. As such, it is an attrac-
tive target for proteogenomic annotation. In this study,
we applied high-throughput shotgun proteomic technol-
ogy to explore the comprehensive protein expression
profile of S. flexneri 2a str.301. We completely validated
823 protein products, including hundreds of hypothetical
proteins. We also corrected several start sites with the
help of our original N-terminal extension database.
Furthermore, certain novel open reading frames (ORFs)
were confirmed by combining MS analysis and RT-PCR.
Our findings suggest that current genome annotations
are not yet complete, and that proteogenomic tools have
the potential to validate and complement genome wide
annotation.
Results and Discussion
Validation of annotated ORFs in the S. flexneri 2a str.301
genome
Raw MS/MS data were used to search a database contain-
ing all six possible reading frames of the entire S. flexneri
2a str.301 genome, using Mascot version 2.2. Applying the
filtering criteria described in the Methods section, 823
ORFs from all experiments were unambiguously assigned,
of which 811 were previously annotated in the S. flexneri
2a str.301 genome database from NCBI. (Additional file 1,
Table S1). On average, between 2 or 3 peptides were used
to identify each ORF, and the amino acid sequence cover-
age for the detected ORFs averaged 13%. The distribution
patterns of pI, Mr, and grand average of hydropathicity
(GRAVY) of the identified proteins were similar to those
of all S. flexneri 2a str.301 annotated proteins (Additional
file 2, Figure S1-A, B, C). For example, the pI patterns of
the identified proteins had the characteristic bimodal dis-
tribution, which was previously observed for bacterial and
archaeal genomes [27]. Moreover, these proteins (20 of 22
groups in clusters of orthologous groups of proteins,
COGs) were involved in nearly all major biological pro-
cesses (Additional file 2, Figure S2-A, B). Hypothetical
proteins were likely to have been annotated incorrectly
because of the lack of experimental evidence, and required
further experimental validation. In our study, 187 hypothe-
tical or putative ORFs were validated at the protein level,
representing 10% of the 1944 predicted hypothetical pro-
teins of S. flexneri 2a str.301. This was below the average
detection rate of all other annotated proteins. Thus, these
data suggested that a certain proportion of the hypotheti-
cal protein products do not exist in the organism, and
represent misannotation of the corresponding genomic
region [7,17]. The rest of the peptides that were detected
with MS but did not match any annotated protein, are
analyzed in detail below. A complete list of identified pep-
tides and their quality scores are given in Additional file 1,
Table S1.
Correction of gene annotation errors
Correction of start codon errors
Traditionally, it has been difficult to correctly identify the
TSS within a given sequence. For example, a previous
study of 143 annotated prokaryotic genomes showed that
approximately 60% of the genes might have incorrectly-
assigned TSSs [2]. While accurate prediction of TSSs is
critical for defining protein sequences, as well as intergenic
regions that might contain transcriptional regulatory ele-
ments [16]. TSSs were usually verified by N-terminal
sequencing analysis. This method was often technically
demanding and was not amenable to the majority of pro-
teins with ‘blocked’, and therefore inaccessible, N-termini
[28]. To amend the approximate location of TSSs in these
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pler than N-terminal sequencing and is also capable of
high-throughput analysis, as it is possible that wrongly
assigned start sites could be validated and corrected in a
single experiment using this method.
All MS-derived peptides were screened against both the
S. flexneri 2a str.301 protein database (downloaded from
NCBI) and the customized N-terminal extension database
(see Methods section). Peptide hits using the latter indi-
cated that the 5’ end of the corresponding gene should be
expanded. As a result, three genes (yhdp, yebj, and smpA)
were identified as having true start codons upstream of
their current start codons (Table 1; Additional file 2,
Figure S3). In addition, by performing a BLASTP search
against GenBank, the N-terminus extended proteins other
than the original proteins shared higher similarities with
their homologs in other bacteria (data not shown). More-
over, we successfully designed primers based on the N-
terminal extension region for RT-PCR experiments to
confirm the existence of the three extended genes (Addi-
tional file 2, Figure S4), suggesting that the N-terminal
extensions inferred by our method were reliable. The
initial codons of all three genes were corrected and
updated in GenBank entries based on our new evidence.
This original strategy of combining both N-terminal pro-
teomic analysis and transcriptional verification represents
an effective and promising means for experimental identi-
fication of TSSs. We expect that this strategy can be
applied to other organisms.
Correction of sequencing errors
Although genome sequencing technologies have made
great progress in the last 10 years, none of these next-
generation sequencing methods are 100% accurate. There
are usually a few wrong bases in an otherwise accurate
genome. With the aid of proteogenomic tools, we could
uncover genes that contained certain avoidable sequen-
cing errors, which usually led to erroneous annotations.
For example, we found an ORF (fusA)i nS. flexneri 2a
str.301, which was 240 bp shorter at the 3’ end than its
homologs in other Shigella genomes. However, our MS/
MS data identified peptides matching the missing part of
fusA (BIO01150) in S. flexneri 2a str.301 (Figure 1A). To
test if a stop codon mutation resulted from a sequencing
error, we re-sequenced the coding region of fusA and
found that the guanine at genome position 3, 440, 920
was previously recognized as thymine, because of a
mistake in the initial genome sequencing project. This
sequencing error led to a transformation from GAA (cod-
ing Glu) to the premature termination codon TAA
(Figure 1A). As a result, the 3’ end of the fusA gene anno-
tated in S. flexneri 2a str.301 should be extended from 3,
440, 918 to 3, 440, 678. Importantly, this gene is now seen
to encode a full-length protein product.
Bacterial pseudogenes were originally considered to be
infrequent. Despite having DNA sequences similar to
those of known genes, pseudogenes were regarded as
disabled copies of functional genes [29]. Nonetheless, we
detected two peptide segments matching the protein
product of the zwf (BIO80170) pseudogene, which was
orthologous to E. coli K12 glucose-6-phosphate dehy-
drogenase (Figure 1B). Was the zwf gene in S. flexneri
2a str.301 a true pseudogene? Further re-sequencing of
the regional genomic sequence revealed that there was
an extra adenine insertion into the coding region of zwf
in the original S. flexneri 2a str.301 genome sequence,
which resulted in frame-shift introducing a premature
stop codon (Figure 1B). As such, based on our proteoge-
nomic finds, the zwf pseudogene in S. flexneri 2a str.301
was revised to encode a functional full-length product.
The yraJ gene, which encodes an outer membrane usher
protein in other enterobacteria, was disrupted by an IS2
insertion sequence in S. flexneri 2a str.301. Using the
six-reading-frame database search, we identified this
pseudogene’s premature protein product (BIO11778). Its
transcript was also detected by RT-PCR (Additional file
2, Figure S5). Previous studies revealed that the intact
usher protein assembled in the OM as a dimeric secre-
tion complex [30]. From an evolutionary standpoint, it
has been considered that transcribed/translated pseudo-
genes were not necessarily without function. How the
premature protein functions remains to be determined.
Discovery of novel ORFs
The most striking result of our study was the identifica-
tion of novel ORFs. All assigned ORFs were aligned with
the current annotated ORFs of S. flexneri 2a str.301 using
BLASTP, and those that aligned with annotated proteins
were discarded. As a result, we detected 7 novel ORFs
that were not predicted in S. flexneri 2a str.301 by any
other annotation pipelines (see Table 2). Among these
novel ORFs, four ORFs have orthologs in other closely-
related organisms, which allowed substantial cross-
species validation of the new genes. Significantly, the
other three ORFs were completely novel genes that had
no homology with other annotated proteins from any
species.
We focused on the seven novel genes to further investi-
gate why they escaped computational prediction. First,
these novel ORFs were relatively short. To our knowl-
edge, short CDSs (especially less than 150 nucleotides)
are among the most difficult genomic features to predict
and are often missed during the annotation process due
to conservative calls [8]. On the other hand, most of the
identified novel ORFs were partially or entirely over-
lapped by annotated longer ORFs (Table 2; Additional
file 2, Figure S6). For gene prediction software, the
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Page 3 of 9Table 1 N-terminal extension of three genes
Gene Tag Predicted start site Updated state site Old start codon New start codon Peptides matching N-terminal extension database Peptide score
yhdP BIO47422 3382990 3383830 GTG GTG DLTFWQLR 52
yebJ BIO00465 1434566 1433987 GTG ATG IGIFQDLVDR 55
VDLDGNPCGELDEQHVEHAR 101
smpA BIO00925 2752334 2752145 ATG ATG VVYRPDINQGNYLTANDVSK 85
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9percentage of missing genes is strongly correlated with
the frequency of gene overlaps. In Glimmer, the maxi-
mum overlap length is set to 30 bp by default [31]. Gen-
erally, the relatively longer ORF rather than its
overlapping genes is likely to be retained. Unfortunately,
those omitted overlapping genes might be true genes
[23]. As Figure S6 shown, generally there were four pat-
terns for the relative locationo fo v e r l a p p i n gg e n ep a i r s .
Figure 1 Examples of sequencing errors identified by proteogenomic analysis. (A) The nucleotide and corresponding amino acid
sequences of the fusA gene. The ‘G’ at genome position 3, 440, 920 was previously erroneously recognized as ‘T’, resulting in a stop codon
mutation. (B) The nucleotide and corresponding amino acid sequences of the zwf gene and its pseudogene. An extra ‘A’ at genome position 1,
899, 437 resulted in a frameshift that caused a premature termination mutation. These two sequencing errors were corrected in GenBank entries
on our request. Unambiguously assigned peptides and sequencing error bases are boxed. *, stop codon.
Table 2 Characteristics of seven novel ORFs
Gene tag Strand Length
(AA)
Overlaps
a) Annotation in other enterobacteria
BIO01608
b) + 80 No Hypothetical protein
BIO50043
b) - 365 Partial (S) Sulfate/thiosulfate transporter subunit
BIO07235
b) + 25 Partial (S) None
BIO43803
b) - 496 Partial (C) Hypothetical protein
BIO68373 - 59 Nested (C) Conserved hypothetical protein
BIO58539 - 86 Nested (S) None
BIO48527 - 36 Nested (S) None
a) No, ORFs not overlapping other genes; Partial (C), ORFs partially overlapping known genes on the complementary strand; Partial (S), ORFs partially overlapping
known genes on the same strand; Nested (C), ORFs completely contained within known genes on the complementary strand; Nested (S), ORFs completely
contained within known genes on the same strand, but in a different frame.
b) The transcripts of novel ORFs were confirmed by RT-PCR assay.
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overlap with known genes and other three ORFs
(BIO50043, BIO07235, BIO43803) respectively belonged
to pattern I or pattern II, whose transcripts were easy to
be verified by RT-PCR assays. The results showed that
the transcripts of four ORFs were specifically detected
(Figure 2), and additional sequencing of these PCR pro-
ducts confirmed their identity. The rest three ORFs
(BIO58539, BIO48527, BIO68373) were entirely con-
tained within the coding region of certain longer known
genes (Pattern III or Pattern IV), referred to as “nested”
genes. Although nested genes are quite rare in prokaryotic
genomes, this kind of gene arrangement is beginning to be
recognized, such as setBA /pic in S. flexneri 2a [32,33],
ins5B /ins5A and hgtA/yaaWi nE. coli [34,35], and
Pfl01_0939/cosA in P. Fluorescens [36]. The existence of
nested genes increases the organizational complexity of the
genome structure, so it is not practical to investigate all
gene arrangements during conventional genome annota-
tion. As such, proteogenomic methods offer a promising
avenue toward the experimental validation of nested genes
at the protein level [37].
Short CDSs remain largely unknown, even though
small peptides encoded by short genes are involved in
diverse functions, such as secretion, stress responses,
metabolism, and gene regulation in bacteria [38,39]. We
also examined the gene structure of each of the seven
novel genes. In our study, there were no identifiable
functional domains in the seven novel ORFs, with the
exception of BIO01608 and BIO50043. BIO01608 con-
tains an YmgB superfamily conserved domain, which is
involved in biofilm development and stability. BIO50043
contains an ABC_CysA_sulfate_importer conserved
domain, which is involved in sulfate import, and whose
ortholog in E. coli is annotated as a sulfate/thiosulfate
transporter subunit. Overlapping gene pairs were con-
served among organisms for specific genes and func-
tions. In addition, it was generally assumed that their
expressions were correlated with host genes, which
would reduce the need for more complex regulatory
pathways and thus the regulation of gene expression
would be more effective [1,40]. For example, of the
setBA /pic nested gene pair in S. flexneri 2a, the pic
gene encodes mucinase, which is involved in mucosal
colonization, and set1A and set1B encode the two subu-
nits of the ShET1 enterotoxin. The two partners were
likely to be expressed reciprocally and function coopera-
tively [41], which aided our further investigation of the
function of nested gene pair. Exploring these novel
nested genes’ biological functions and their coordination
with host genes are under investigation.>
Conclusions
In our study, the detection of annotation errors, such as
incorrect start sites assignment, sequencing errors, and
wrongly annotated pseudogenes, would prevent misanno-
tation from being multiplied in future versions of the S.
flexneri 2a str.301 genome. The findings of novel ORFs
would also provide a new clue to conduct functional
research. Moreover, some of the novel ORFs were identi-
fied as overlapping genes, which increases our understand-
ing of the complexity of the genome structure and reveals
the underestimation of such gene arrangements. This
updated dataset would be very helpful for those interested
in this pathogen to unearth certain information previously
omitted. With the rapid development of proteomic tech-
nology, all sequence-based genome projects could be sup-
plemented by the proteogenomic analysis.
Methods
Strain and culture conditions
Frozen S. flexneri 2a, str.301 (kindly provided by the
ICDC, China CDC) cell stocks were streaked onto tryptic
soy agar containing 0.01% Congo red. An individual red
colony was subsequently transferred into tryptic soy
broth (TSB) and grown overnight at 37°C with rotary
shaking at 200 rpm. The overnight culture was diluted
1:50 in fresh TSB and incubated under the same condi-
tions until OD600 = 0.6-1.0. Cells were harvested by 8
min centrifugation at 2, 500 × g at 4°C and then washed
twice ice-cold 50 mM Tris-HCl, pH 7.3. The pelleted
cells were frozen at -20°C until required.
Figure 2 Validating MS data using RT-PCR. RNA fragments of the
expected sizes were observed, indicating that these un-annotated
genes are transcribed. Figure shows the RT-PCR verification results
for six novel genes. Amplified PCR products were electrophoresed
on a 2.5% agarose gel and visualized by ethidium bromide staining.
BIO07235, BIO01608, BIO43803, and BIO50043 were amplified and
loaded in lanes 1-4, respectively; a negative control (noncoding
DNA sequence) was loaded in lane 5 (cDNA as template) and lane
6 (genomic DNA as template); Lane 7, positive control
(housekeeping gene, ipaD); Lane M, GeneRuler™ 50 bp DNA Ladder
(Fermentas GmbH, Germany).
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Bacterial cells were resuspended in 100 mM Tris-HCl
buffer (pH 8.5), containing 7 M Urea, 2 M Thiourea, a
protease inhibitor cocktail tablet (Roche Diagnostics,
Germany), and Benzonase Nuclease (25 U/ml, Sigma,
USA), and then ruptured by ultrasonication. The unbro-
ken cells were removed by centrifugation at 4, 000 × g for
10 min at 4°C. The supernatant was diluted with ice cold
100 mM Na2CO3 (pH 11.5) to a final pH 11 and stirred
slowly on ice for 1 h. The supernatant was further col-
lected by ultracentrifugation in a Beckman SW 40Ti
rotor at an average of 150, 000 × g for 1 h at 4°C. The
supernatant was analyzed for cytosolic protein compo-
nents. The membrane pellet was resuspended and
washed twice in ice-cold 100 mM Na2CO3 (pH 11.5) at
4°C. Finally, the washed membrane sheets were pelleted
by ultracentrifugation at an average of 150, 000 × g for
45 min and resuspended in 100 mM NH4HCO3 contain-
ing 7 M Urea and 2 M Thiourea [42]. Cytosolic and
membrane fractions were measured for protein content
using a bicinchoninic acid (BCA) assay. Both of fraction
samples were analyzed in parallel and replicated three
times.
In-solution digest
Cytosolic and membrane fractions were reduced in the
presence of 10 mM DTT at 37°C for 45 min, and then
alkylated in the presence of 50 mM iodacetamide at
room temperature in the dark for 30 min. The reaction
products were diluted to 1 M urea and digested with
trypsin (1:50 w/w, modified sequencing grade, Promega,
USA) overnight at 37°C. Peptides were desalted using an
Oasis HLB extraction cartridge (Waters, USA). All pep-
tide fractions were concentrated with a Speed-vac cen-
trifuge (Eppendorf, Germany) and resolubilized in 0.1%
TFA for the following two-dimensional liquid chromato-
graphy matrix-assisted laser desorption/ionization (2D
LC-MALDI) analysis.
2D LC-MALDI analysis
Digested peptide mixtures were separated using the Ulti-
mate 3000 HPLC system (Dionex-LC-Packings, USA)
coupled with a PROTEINEER fc LC-MALDI fraction col-
lector (Bruker, Germany). The HPLC system consisted of
a strong cation exchange (SCX) column (300 μmi d
POROS 10S Column, Dionex) and a C18 reverse-phase
microcapillary column (PepMap100 C18, 300 μm, 100Å,
Dionex). The flow rate through the column was 2 μl/min.
The solutions used were as follows: 0.05% TFA in water
(buffer A), 0.04% TFA in 80% ACN (buffer B). A sample
of the desired peptides digest was loaded onto the SCX
column. NaCl of different concentration at 0.5, 1, 2, 3, 5,
10, 25, 50, 100, 200, 500, 1000 mM was used to displace
peptide fractions from the SCX column onto the RP
column, respectively. Each case was synchronized with a
90 min RP gradient. Gradient conditions: isocratic pre-
run at 4% B, 0-5 min; linear gradient 4-65% B, 5-65 min;
65-100% B, 65-70 min, column wash at 100% B, 70-75
min; re-equilibrate the column at 4% B, 75-90 min.
Online MALDI spotting of LC fractions was carried as
follows: number of fractions, 384 (covering the gradient
4-65% B); MALDI target, Pre-spotted disposable
AnchorChip PAC 384 HCCA target (Bruker, Germany);
fraction width, 15 s (500 nl). MS spectra were automati-
cally acquired on an Ultraflex III MALDI-TOF/TOF
mass spectrometer (Bruker Daltonics, Germany) in the
positive reflection mode under the control of Compass
1.2 and WARP-LC 1.0 software (Bruker Daltonics, Ger-
many). The parameter settings were: 20 kV accelerating
voltage and 23 kV reflecting voltage; MS and MS/MS
mass range: m/z 700-4000 and 50-2000, respectively;
Detected peptide compounds with a signal-to-noise ratio
higher than 10 were subjected to MALDI-time of flight
(TOF) MS/MS analysis.
In-house database construction
We translated the S. flexneri 2a str.301 genome (down-
loaded from NCBI) into all six possible reading frames,
generating a set of all possible peptides (larger than 15
amino acids) that could be encoded. Sequences for com-
mon contaminants from two collections (248 from Max
Planck Institute of Biochemistry, 112 from the Global
Proteome Machine Organization Common Repository of
Adventitious Protein), were merged into one (total 338
unique entries) and appended to the end of the above
target database FASTA file. The final database had 90330
entries. To detect potential extended TSSs of the pre-
dicted coding sequences, we constructed a specialized N-
terminal extension database, using a similar strategy as
previously described [16] with some changes. The data-
base took into account all currently annotated CDSs
from the S. flexneri 2a str.301 genome. The region
upstream of each CDS was scanned until an in-frame
stop codon was identified. Then, the in-frame codons
downstream of this stop codon were scanned for the first
location of a start codon (ATG, GTG or TTG). The pep-
tide from the new start codon to the 33rd amino acid
residue downstream of original start site was collected
into the extension database, except for those CDSs whose
start codon was the same as the previous annotation. As
a result, 1311 peptides were collected in the customized
extension database (Additional file 3, Table S2).
Data evaluation
MS/MS data were searched using Biotools 3.1 software
(Bruker Daltonics, Germany) with MASCOT 2.2 plugin
http://www.matrixscience.com against the six reading
frame translation of S. flexneri 2a str.301 genome. All
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[43]http://www.ebi.ac.uk/pride/ and could be downloaded
from this URL: http://www.mgc.ac.cn/Resources/
mzXML_S.flexneri_WARP-LC.tgz. The following search
parameters were applied: max missed cleavage: 1; fixed
modification: Carbamidomethylation (C); variable modifi-
cation: Oxidation (M), Carbamyl (N-term), Deamidated
(NQ); precursor ion mass tolerance: ± 50 ppm; fragment
mass tolerance: ± 0.6 Da. Decoy searches were performed
using the automated ‘Decoy’ search option from Mascot.
In this strategy, Mascot will generate and search a random
version of each target database protein. The false discovery
rate (FDR) is calculated as follows:
FDR = Decoy hits(FP)/Target hits (FP + TP).
We tweaked the peptide significance threshold (at most
0.01) to control the FDR value under 1%. Under these cri-
teria, all the proteins with at least one unique peptide
identification at p < 0.01 were considered likely to be pre-
sent in the sample. Additionally, total proteins identified
by a single peptide and all novel protein identifications
could not be accepted unless their corresponding MS/MS
spectra passed the manual validation. All spectra used for
annotated ORF identifications based on unique peptides
(ion score < 45), as well as all those of novel ORFs are
shown in Additional file 4.
RT-PCR
Total RNA of S. flexneri 2a str.301 was extracted using
the SV Total RNA Isolation System Kit (Promega, USA)
following the manufacturer’s protocol. Total RNA was
treated with RQ1 RNase-free DNase (Promega, USA) to
remove residual genomic DNA, followed by heat inacti-
vation of the endonuclease. cDNA synthesis was per-
formed from 1 μg of RNA using the SuperScript™ III
Reverse Transcriptase (Invitrogen, USA) according to the
manufacturer’s protocol. PCR was performed using 1 μl
of the reverse transcription reaction as a starting material
according to standard procedures. PCR cycling para-
meters were typically 4 min at 94°C; 30 cycles of 30 s at
94°C, 30 s at 55°C, 30 s at 72°C; and a final 10 min exten-
sion at 72°C. The RT-PCR assay was run with the house-
keeping gene (ipaD) as a positive control and a non-
coding DNA sequence (from 417, 540 to 417, 690 in the
S. flexneri 2a str.301 genome) as the negative control.
Gene-specific primers used to amplify the target genes
are listed in Additional file 5, Table S3.
Additional material
Additional file 1: Supplementary Table S1, All proteins identified by
MS analysis. This file contains detailed information of all identified
proteins in our study.
Additional file 2: Supplementary Figures. This file contains
supplementary Figures S1-6. Figure S1 illustrates the patterns of pI, Mr,
and GRAVY value of identified/annotated proteins. Figure S2 illustrates
COGs functional categories of identified/annotated proteins. Figure S3
shows the information about N-terminal extension of three genes. Figure
S4 shows RT-PCR results of three extended genes. Figure S5 shows
RT-PCR results for BIO11778. Figure S6 illustrates patterns for relative
location of novel ORFs overlapping known genes.
Additional file 3: Supplementary Table S2, List of candidate
N-terminal extension genes. This file contains a list of genes that are
likely to be extended at the N-terminus in the S. flexneri 2a str.301
genome. Each entry’s information includes locus tag, extension region:
genome position of region from N-terminal new start codon to the 33rd
amino acid residue downstream of original start site for each extended
gene, and the peptide sequence corresponding to extension region.
Additional file 4: Manually validated MS/MS spectra. This file shows
all MS/MS spectra of peptides matching to annotated proteins that had
a single peptide hit (ion score < 45) and un-annotated novel proteins.
Additional file 5: Supplementary Table S3. Table S3 shows a list of
primers used in this article.
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